Celcuity, Inc. (CELC)
92.27
+1.48
(+1.63%)
USD |
NASDAQ |
Aug 25, 16:00
92.20
-0.07
(-0.08%)
After-Hours: 19:59
Celcuity Shareholders Equity (Quarterly) : -12.78M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.78M |
| March 31, 2026 | 53.52M |
| December 31, 2025 | 100.56M |
| September 30, 2025 | 116.96M |
| June 30, 2025 | 44.38M |
| March 31, 2025 | 86.67M |
| December 31, 2024 | 115.62M |
| September 30, 2024 | 149.71M |
| June 30, 2024 | 176.68M |
| March 31, 2024 | 133.74M |
| December 31, 2023 | 139.77M |
| September 30, 2023 | 92.90M |
| June 30, 2023 | 110.13M |
| March 31, 2023 | 123.23M |
| December 31, 2022 | 133.77M |
| September 30, 2022 | 43.53M |
| June 30, 2022 | 53.19M |
| March 31, 2022 | 61.54M |
| December 31, 2021 | 68.71M |
| Date | Value |
|---|---|
| September 30, 2021 | 74.47M |
| June 30, 2021 | 27.03M |
| March 31, 2021 | 35.17M |
| December 31, 2020 | 11.70M |
| September 30, 2020 | 13.76M |
| June 30, 2020 | 15.86M |
| March 31, 2020 | 17.52M |
| December 31, 2019 | 19.30M |
| September 30, 2019 | 20.71M |
| June 30, 2019 | 22.39M |
| March 31, 2019 | 23.86M |
| December 31, 2018 | 25.35M |
| September 30, 2018 | 26.91M |
| June 30, 2018 | 28.48M |
| March 31, 2018 | 29.94M |
| December 31, 2017 | 31.39M |
| September 30, 2017 | 32.81M |
| June 30, 2017 | 4.335M |
| March 31, 2017 | 4.720M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 532.39M |
| Replimune Group, Inc. | 105.64M |
| Erasca, Inc. | 361.87M |
| Apogee Therapeutics, Inc. | 1.195B |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 828.22M |
| Total Liabilities (Quarterly) | 841.00M |
| Debt to Equity Ratio | -59.02 |
| Current Ratio | 8.931 |
| Net Debt Paydown Yield | -2.56% |